Sodium-glucose cotransporter 2 (SGLT2) inhibition improves alpelisib (ALP)-induced hyperglycemia in Zucker diabetic fatty (ZDF) rats

被引：0
|
作者：
Schnell, C. [1 ]
Ferrat, T. [1 ]
Schwarzmueller, A. [1 ]
Gao, J. [2 ]
Fritsch, C. [1 ]
机构：
[1] Novartis Inst Biomed Res, Oncol Res, Basel, Switzerland
[2] Novartis Inst Biomed Res, Cardiovasc & Metab Dis, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
39
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1
    Lu, Y-S.
    Chiu, J.
    Airoldi, M.
    Margeli Vila, M.
    Ponce Lorenzo, J.
    Ghaznawi, F.
    Gaudenzi, F.
    Ridolfi, A.
    Lorenzo, I.
    Ruiz Borrego, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S363 - S363
  • [2] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke
    Kimura, Genjiro
    CIRCULATION JOURNAL, 2017, 81 (06) : 898 - 898
  • [3] Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lusk, Kathleen A.
    Barnes, Nicole E.
    US PHARMACIST, 2016, 41 (11) : 38 - 42
  • [4] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke - Reply
    Kaku, Kohei
    Lee, Jisoo
    Kaspers, Stefan
    Woerle, Hans J.
    George, Jyothis T.
    CIRCULATION JOURNAL, 2017, 81 (06) : 899 - 899
  • [5] Normalization of Hyperglycemia by Inhibiting SGLT2 Prevents Progressive Reduction of Hepatic Glucokinase (GK) Expression and Improves Hepatic Glucose Metabolism (HGM) in Zucker Diabetic Fatty (ZDF) Rats
    Ueta, Kiichiro
    Torres, Tracy P.
    McCoy, Gregory L.
    Farmer, Tiffany D.
    Condren, Audree B.
    Whitfield, Thomas
    Printz, Richard L.
    Shiota, Masakazu
    DIABETES, 2010, 59 : A166 - A166
  • [6] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
    Mahling, Moritz
    Schork, Anja
    Nadalin, Silvio
    Fritsche, Andreas
    Heyne, Nils
    Guthoff, Martina
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 984 - 992
  • [7] Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats
    Osorio, Horacio
    Coronel, Israel
    Arellano, Abraham
    Franco, Martha
    Escalante, Bruno
    Bautista, Rocio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (02) : 276 - 282
  • [8] Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats
    Hofmann, Anja
    Brunssen, Coy
    Peitzsch, Mirko
    Martin, Melanie
    Mittag, Jennifer
    Jannasch, Anett
    Engelmann, Felix
    Brown, Nicholas F.
    Weldon, Steven M.
    Huber, Jochen
    Streicher, Ruediger
    Deussen, Andreas
    Eisenhofer, Graeme
    Bornstein, Stefan R.
    Morawietz, Henning
    ENDOCRINOLOGY, 2016, 157 (10) : 3844 - 3855
  • [9] The Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Dapagliflozin Causes Ketosis In Nondiabetic and Diabetic Mice
    Coch, Reilly
    Campbell, Jonathan
    D'Alessio, David A.
    DIABETES, 2017, 66 : A349 - A349
  • [10] Diabetes Leads to Sodium-Glucose Cotransporter 2 (SGLT2) Increase in the Retina
    Leley, Sameer P.
    Luo, Qianyi
    Alex, Alpha L.
    Bhatwadekar, Ashay D.
    DIABETES, 2019, 68
12345